A Novel Immunogenic Mouse Model of Melanoma for the Preclinical Assessment of Combination Targeted and Immune-Based Therapy

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-37883-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Preclinical Assessment of Antiviral Combination Therapy in a Genetically Humanized Mouse Model for Hepatitis Delta Virus Infection

Science Translational Medicine
Medicine
2018English

Immunocompetent Mouse Model of Breast Cancer for Preclinical Testing of EphA2-targeted Therapy

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2004English

1210 Enhancing the Therapeutic Efficacy of Immune Checkpoint Inhibition and Targeted Therapy Using Anti-Tumor Antibodies in Mouse Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Combination of Immunotherapy With Targeted Therapy: Theory and Practice in Metastatic Melanoma

Frontiers in Immunology
AllergyImmunology
2019English

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Mitochondria-Targeted Therapy for Metastatic Melanoma

English

Preclinical Development of Targeted Stereotactic Body Radiation Therapy for Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Rechallenge of Targeted Therapy in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2019English

Preclinical Efficacy of a PSMA-targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy